• 1
    Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79.
  • 2
    Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575.
  • 3
    Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006;2:367-73.
  • 4
    Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713.
  • 5
    Conus F, Rabasa-Lhoret R, Péronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007;32:4-12.
  • 6
    Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999;48:2210-2214.
  • 7
    Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168:1609-1616.
  • 8
    Blüher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 2010;21:38-43.
  • 9
    Wildman RP. Healthy obesity. Curr Opin Clin Nutr Metab Care 2009;12:438-443.
  • 10
    Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.
  • 11
    Peppa M, Koliaki C, Raptis SA. Body composition as an important determinant of metabolic syndrome in postmenopausal women. Endocrinol Metab Syndrome 2012; doi: 10.4172/2161-1017.S1-009.
  • 12
    Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020-1025.
  • 13
    Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) 2010;18:911-917.
  • 14
    Messier V, Karelis AD, Robillard ME, et al. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 2010;59:20-24.
  • 15
    Glickman SG, Marn CS, Supiano MA, Dengel DR. Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity. J Appl Physiol 2004;97:509-514.
  • 16
    Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med 2007;44:335-340.
  • 17
    Craig C, Marshall A, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395.
  • 18
    Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150.
  • 19
    Brochu M, Mathieu ME, Karelis AD, et al. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study. Obesity (Silver Spring) 2008;16:1085-1093.
  • 20
    Peppa M, Koliaki C, Papaefstathiou A, Garoflos E, Katsilambros N, Raptis SA, Hadjidakis D, Dimitriadis G. Body composition determinants of metabolic phenotypes of obesity in non-obese and obese postmenopausal women. Obesity 2012 (in press, DOI: 10.1002/oby.20227).
  • 21
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
  • 22
    Shea JL, Randell EW, Sun G. The prevalence of metabolically healthy obese subjects defined by BMI and Dual-energy X-ray absorptiometry. Obesity (Silver Spring) 2010 (Epub ahead of print).
  • 23
    Karelis AD, Rabasa-Lhoret R. Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 2008;34:183-184.
  • 24
    Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
  • 25
    Hayes L, Pearce MS, Firbank MJ, Walker M, Taylor R, Unwin NC. Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC Public Health 2010;10:723.
  • 26
    Grundy SM, Brewer HB, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438.
  • 27
    Robillard ME, Bellefeuille P, Comtois AS, Aubertin-Leheudre M, Karelis AD. The metabolically healthy but obese postmenopausal woman presents a favourable heart rate variability profile. Scand Cardiovasc J 2011 (Epub ahead of print).
  • 28
    Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002;282:E1023-E1028.
  • 29
    Park YW, Heymsfield SB, Gallagher D. Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int J Obes Relat Metab Disord 2002;26:978-983.
  • 30
    Lee CC, Glickman SG, Dengel DR, Brown MD, Supiano MA. Abdominal adiposity assessed by dual energy X-ray absorptiometry provides a sex-independent predictor of insulin sensitivity in older adults. J Gerontol A Biol Sci Med Sci 2005;60:872-877.
  • 31
    Wiklund P, Toss F, Weinehall L, et al. Abdominal and gynoid fat mass are associated with cardiovascular risk factors in men and women. J Clin Endocrinol Metab 2008;93:4360-4366.
  • 32
    Ito H, Nakasuga K, Ohshima A, et al. Detection of cardiovascular risk factors by indices of obesity obtained from anthropometry and dual-energy X-ray absorptiometry in Japanese individuals. Int J Obes Relat Metab Disord 2003;27:232-237.
  • 33
    Brownell KD, Rodin J. Medical, metabolic, and psychological effects of weight cycling. Arch Intern Med 1994;154:1325-1330.
  • 34
    Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003;26:2341-2344.
  • 35
    Peppa M, Koliaki C, Boutati E, et al. Discriminant features of “Metabolically Healthy Obese” and “Metabolically Obese Normal Weight” phenotypes in healthy postmenopausal women. Diabetologia 2011;54( Suppl 1):666.
  • 36
    Peppa M, Koliaki C, Boutati E, Garoflos E, Papaefstathiou A, Siafakas N, Katsilambros N, Raptis SA, Hadjidakis D, Dimitriadis G. Association of lean body mass with cardiometabolic risk factors in healthy postmenopausal women. Obesity 2012 (in press).